• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国 2020 年 12 月至 2023 年 5 月期间的 COVID-19 疫苗分发策略、系统、绩效和经验教训。

U.S. COVID-19 vaccine distribution strategies, systems, performance, and lessons learned, December 2020 - May 2023.

机构信息

National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA, United States.

National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA, United States.

出版信息

Vaccine. 2024 Sep 17;42 Suppl 3(Suppl 3):125703. doi: 10.1016/j.vaccine.2024.02.020. Epub 2024 Feb 15.

DOI:10.1016/j.vaccine.2024.02.020
PMID:38360476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11366301/
Abstract

During December 2020 through May 2023, the Centers for Disease Control and Prevention's (CDC) Immunization Services Division supported and executed the largest vaccine distribution effort in U.S. history, delivering nearly one billion doses of COVID-19 vaccine to vaccine providers in all 50 states, District of Columbia, Puerto Rico, Virgin Islands, Guam, Federated States of Micronesia, American Samoa, Marshall Islands, Northern Mariana Islands, and Palau. While existing infrastructure, ordering, and distribution mechanisms were in place from the Vaccines for Children Program (VFC) and experience had been gained during the 2009 H1N1 pandemic and incorporated into influenza vaccination pandemic planning, the scale and complexity of the national mobilization against a novel coronavirus resulted in many previously unforeseen challenges, particularly related to transporting and storing the majority of the U.S. COVID-19 vaccine at frozen and ultra-cold temperatures. This article describes the infrastructure supporting the distribution of U.S. government-purchased COVID-19 vaccines that was in place pre-pandemic, and the infrastructure, processes, and communications efforts developed to support the heightened demands of the COVID-19 vaccination program, and describes lessons learned.

摘要

2020 年 12 月至 2023 年 5 月,疾病预防控制中心(CDC)免疫服务司支持并执行了美国历史上最大规模的疫苗分发工作,向全美 50 个州、哥伦比亚特区、波多黎各、维尔京群岛、关岛、密克罗尼西亚联邦、美属萨摩亚、马绍尔群岛、北马里亚纳群岛和帕劳的疫苗提供者分发了近 10 亿剂 COVID-19 疫苗。虽然现有的基础设施、订购和分发机制来自儿童疫苗计划(VFC),并且在 2009 年 H1N1 大流行期间获得了经验,并纳入了流感疫苗大流行规划,但针对新型冠状病毒的全国动员规模和复杂性导致了许多以前未曾预料到的挑战,特别是与运输和储存大多数美国 COVID-19 疫苗的冷冻和超冷温度有关。本文描述了在大流行之前支持分发美国政府购买的 COVID-19 疫苗的基础设施,以及为支持 COVID-19 疫苗接种计划的更高需求而开发的基础设施、流程和通信工作,并描述了所吸取的经验教训。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c6/11366301/7bcf3afa871a/nihms-2012891-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c6/11366301/443ed1a549b0/nihms-2012891-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c6/11366301/27ff348a6ba4/nihms-2012891-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c6/11366301/7bcf3afa871a/nihms-2012891-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c6/11366301/443ed1a549b0/nihms-2012891-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c6/11366301/27ff348a6ba4/nihms-2012891-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c6/11366301/7bcf3afa871a/nihms-2012891-f0003.jpg

相似文献

1
U.S. COVID-19 vaccine distribution strategies, systems, performance, and lessons learned, December 2020 - May 2023.美国 2020 年 12 月至 2023 年 5 月期间的 COVID-19 疫苗分发策略、系统、绩效和经验教训。
Vaccine. 2024 Sep 17;42 Suppl 3(Suppl 3):125703. doi: 10.1016/j.vaccine.2024.02.020. Epub 2024 Feb 15.
2
Operationalizing the Centers for Disease Control and Prevention's Vaccinate With Confidence Framework During the COVID-19 Emergency Response in the United States.将疾病预防控制中心的“有信心地接种疫苗”框架运用到美国 COVID-19 紧急应对期间。
Health Promot Pract. 2024 Nov;25(6):933-938. doi: 10.1177/15248399231188106. Epub 2023 Jul 31.
3
Design and Implementation of a Federal Program to Engage Community Partners to Reduce Disparities in Adult COVID-19 Immunization Uptake, United States, 2021-2022.设计并实施联邦项目,鼓励社区合作伙伴参与,以减少美国成年人 COVID-19 疫苗接种率的差异,2021-2022 年。
Public Health Rep. 2024 Jul-Aug;139(1_suppl):23S-29S. doi: 10.1177/00333549231208642. Epub 2023 Dec 18.
4
Vaccination coverage among children enrolled in Head Start programs or day care facilities or entering school.参加启蒙计划、日托机构或即将入学的儿童的疫苗接种覆盖率。
MMWR CDC Surveill Summ. 2000 Sep 22;49(9):27-38.
5
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season.疫苗预防和控制季节性流感:美国免疫实践咨询委员会在 2021-22 流感季的建议。
MMWR Recomm Rep. 2021 Aug 27;70(5):1-28. doi: 10.15585/mmwr.rr7005a1.
6
Advancing public health informatics during the COVID-19 pandemic: Lessons learned from a public-private partnership with pharmacies.推进 COVID-19 大流行期间的公共卫生信息学:与药店建立公私合作伙伴关系的经验教训。
Vaccine. 2024 Sep 17;42 Suppl 3(Suppl 3):125667. doi: 10.1016/j.vaccine.2024.01.092. Epub 2024 Feb 1.
7
Monitoring and reporting the US COVID-19 vaccination effort.监测和报告美国 COVID-19 疫苗接种工作。
Vaccine. 2024 Sep 17;42 Suppl 3(Suppl 3):125495. doi: 10.1016/j.vaccine.2023.12.005. Epub 2023 Dec 14.
8
Overview of U.S. COVID-19 vaccine safety surveillance systems.美国 COVID-19 疫苗安全监测系统概述。
Vaccine. 2024 Sep 17;42 Suppl 3:125748. doi: 10.1016/j.vaccine.2024.02.065. Epub 2024 Apr 16.
9
An overview of the COVID-19 pediatric vaccine program - The U.S. experience vaccinating children ages 6 months through 17 years.COVID-19 儿科疫苗计划概述 - 美国为 6 个月至 17 岁儿童接种疫苗的经验。
Vaccine. 2024 Sep 17;42 Suppl 3:125702. doi: 10.1016/j.vaccine.2024.02.019. Epub 2024 Feb 29.
10
Strategies to strengthen COVID-19 vaccine uptake and improve vaccine equity in U.S. Territories and Freely Associated States during the first six months of vaccine rollout.在疫苗推广的头六个月,美国领土和自由联系国加强 COVID-19 疫苗接种和改善疫苗公平性的策略。
Vaccine. 2024 Sep 17;42 Suppl 3:125956. doi: 10.1016/j.vaccine.2024.05.005. Epub 2024 May 7.

引用本文的文献

1
Pharmacists' answer to the COVID-19 pandemic: Contribution of the Federal Retail Pharmacy Program to COVID-19 vaccination across sociodemographic characteristics-United States.药剂师对新冠疫情的应对:联邦零售药房计划对美国不同社会人口学特征人群新冠疫苗接种的贡献
J Am Pharm Assoc (2003). 2025 Jan-Feb;65(1):102305. doi: 10.1016/j.japh.2024.102305. Epub 2024 Nov 28.
2
A Scoping Review of Factors Affecting COVID-19 Vaccination Uptake and Deployment in Global Healthcare Systems.影响全球医疗系统中新冠疫苗接种率及推广因素的范围综述
Vaccines (Basel). 2024 Sep 25;12(10):1093. doi: 10.3390/vaccines12101093.
3
Jurisdiction-level costs of the initial phase of the COVID-19 vaccination program in the United States, December 20, 2020-May 31, 2021.

本文引用的文献

1
Monitoring and reporting the US COVID-19 vaccination effort.监测和报告美国 COVID-19 疫苗接种工作。
Vaccine. 2024 Sep 17;42 Suppl 3(Suppl 3):125495. doi: 10.1016/j.vaccine.2023.12.005. Epub 2023 Dec 14.
2
Disparities in COVID-19 Disease Incidence by Income and Vaccination Coverage - 81 Communities, Los Angeles, California, July 2020-September 2021.按收入和疫苗接种率划分的 COVID-19 疾病发病率差距 - 加利福尼亚州洛杉矶,81 个社区,2020 年 7 月至 2021 年 9 月。
MMWR Morb Mortal Wkly Rep. 2023 Jun 30;72(26):728-731. doi: 10.15585/mmwr.mm7226a5.
3
Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021.
2020 年 12 月 20 日至 2021 年 5 月 31 日美国 COVID-19 疫苗接种计划初始阶段的管辖范围成本。
Vaccine. 2024 Oct 24;42(24):126287. doi: 10.1016/j.vaccine.2024.126287. Epub 2024 Sep 3.
使用杨森(强生) COVID-19 疫苗:免疫实践咨询委员会对美国 2021 年 12 月更新的临时建议。
MMWR Morb Mortal Wkly Rep. 2022 Jan 21;71(3):90-95. doi: 10.15585/mmwr.mm7103a4.
4
Overview of the United States' Immunization Program.美国免疫计划概述。
J Infect Dis. 2021 Sep 30;224(12 Suppl 2):S443-S451. doi: 10.1093/infdis/jiab310.
5
Rates of Influenza-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death by Race and Ethnicity in the United States From 2009 to 2019.2009 年至 2019 年美国按种族和族裔划分的流感相关住院率、重症监护病房入院率和住院死亡率。
JAMA Netw Open. 2021 Aug 2;4(8):e2121880. doi: 10.1001/jamanetworkopen.2021.21880.
6
Accelerated COVID-19 vaccine development: milestones, lessons, and prospects.加速 COVID-19 疫苗开发:里程碑、经验教训和前景。
Immunity. 2021 Aug 10;54(8):1636-1651. doi: 10.1016/j.immuni.2021.07.017. Epub 2021 Aug 3.
7
Racial and Ethnic Disparities in COVID-19 Incidence by Age, Sex, and Period Among Persons Aged <25 Years - 16 U.S. Jurisdictions, January 1-December 31, 2020.2020 年 1 月 1 日至 12 月 31 日,年龄<25 岁人群中 COVID-19 发病率的年龄、性别和时期的种族和民族差异-16 个美国司法管辖区。
MMWR Morb Mortal Wkly Rep. 2021 Mar 19;70(11):382-388. doi: 10.15585/mmwr.mm7011e1.
8
Racial and Ethnic Disparities in COVID-19 Outcomes: Social Determination of Health.新冠病毒(COVID-19)在不同种族和民族间的表现差异:健康的社会决定因素。
Int J Environ Res Public Health. 2020 Nov 3;17(21):8115. doi: 10.3390/ijerph17218115.
9
Differential occupational risk for COVID-19 and other infection exposure according to race and ethnicity.根据种族和民族的不同,COVID-19 和其他感染暴露的职业风险差异。
Am J Ind Med. 2020 Sep;63(9):817-820. doi: 10.1002/ajim.23145. Epub 2020 Jun 15.
10
Racial Disparities in Adult Pneumococcal Vaccination Indications and Pneumococcal Hospitalizations in the U.S.美国成人肺炎球菌疫苗接种适应证和肺炎球菌性住院治疗中的种族差异
J Natl Med Assoc. 2019 Oct;111(5):540-545. doi: 10.1016/j.jnma.2019.04.011. Epub 2019 Jun 3.